Vella, Venanzio
Schmidt, Johannes E.
Cilio, Giulia Luna
De Ryck, Iris http://orcid.org/0000-0003-3044-1117
Podda, Audino
Conti, Valentino http://orcid.org/0000-0002-0416-952X
Auerbach, Joachim
Funding for this research was provided by:
GlaxoSmithKline
Article History
Accepted: 28 October 2021
First Online: 18 December 2021
Change Date: 22 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40268-022-00395-2
Declarations
:
: GlaxoSmithKline Biologicals SA covered the costs associated with the development and publishing of the manuscript.
: AP, GLC, IDR, JA, JES, VC, and VV are employees of the GSK group of companies. AP, IDR, JA, JES, and VV hold shares in the GSK group of companies. JA reports grants from the Gates Foundation and Welcome Trust during the conduct of this work. The authors have no non-financial conflicts of interests to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: JES, IDR, AP, JA, VC, VV, and GLC proposed the research question. JES, IDR, AP, JA, VC, and VV participated in the collection of the research data. JES, AP, VC, and VV performed the methodology review. JES, IDR, AP, JA, VC, and GLC interpreted the results. All authors contributed to the development of the manuscript and approved the final version.